Great centralisation of data there thanks Mason. Looks like you can add another disease to Table 5 with the release of this paper last week, The essential role of N6-methyladenosine RNA methylation in complex eye diseases - ScienceDirect. This study appears to have used meclofenamic acid as their FTO inhibitor, looking forward to Zantrene being the inhibitor of choice once word gets out there.
RAC Primer, page-520
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.050(2.86%) |
Mkt cap ! $303.1M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.77 | $80.43K | 44.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5035 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 930 | 1 |
View Market Depth
| Last trade - 15.01pm 10/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |